Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Indane derivatives and the use thereof as soluble guanylate cyclase activators

Indane derivatives and the use thereof as soluble guanylate cyclase activators

US Patent 10316020 · Granted Jun 11, 2019

Estimated economic value: $33,516,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Sustained release delivery systems comprising traceless linkers2025
Sustained delivery of angiopoetin-like 3 polypeptides2022
Methods for inhibiting muscle atrophy2021
Sustained release delivery systems comprising traceless linkers2020
Methods for inhibiting muscle atrophy2020
Tomatidine, analogs thereof, compositions comprising same, and uses for same2020
Indane and indoline derivatives and the use thereof as soluble guanylate cyclase2020
Indane and indoline derivatives and the use thereof as soluble guanylate cyclase2020
Methods for treating ocular disease using inhibitors of CSF-1R2020
Indane and indoline derivatives and the use thereof as soluble guanylate cyclase2019
Indane and indoline derivatives and the use thereof as soluble guanylate cyclase2019
Topical aqueous ophthalmic compositions containing a 1H-indole-1-carboxamide der2019